Balanced news tone
News Sentiment
KARD sentiment intelligence
Kardigan, Inc. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
82/100 classification confidence.
directly relevant articles
high-authority source matches
-14.2% over one week, -4.0% over four weeks, trend inactive, and near fair-value range.
Price to earnings ratio of Kardigan, Inc. – NASDAQ:KARD
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Price to earnings ratio of Kardigan, Inc. – NASDAQ:KARD
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 20 Jul 2026 13:36
- Source
- TradingView
Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Jul 2026 18:49
- Source
- Market source
Kardigan, Inc. (NASDAQ:KARD) Short Interest Up ∞ in June
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 11:58
- Source
- MarketBeat
Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 Jul 2026 07:00
- Source
- Market source
EBITDA of Kardigan, Inc. – NASDAQ:KARD
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2026 01:17
- Source
- TradingView
Kardigan (KARD) Stock Analysis Report | Financials & Insights
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jul 2026 07:00
- Source
- Benzinga
KARD | Kardigan, Inc. Common Stock Institutional Ownership
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Jun 2026 02:18
- Source
- Quiver Quantitative
Kardigan (NASDAQ: KARD) fund boosts stake with 3.13M-share open-market buy
- Tone
- Positive 66/100
- Event
- Deals and strategy
- Published
- 24 Jun 2026 07:00
- Source
- Stock Titan
Biotech stock sends Wall Street surprising signal
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Jun 2026 07:00
- Source
- thestreet.com
Governance shift at Kardigan (NASDAQ: KARD) as new charter and bylaws take effect
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Jun 2026 07:00
- Source
- Stock Titan
Kardigan (KARD) CFO receives 79,640 restricted stock units vesting in 2028
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 07:00
- Source
- Stock Titan
ARCH XIII converts Kardigan (NASDAQ: KARD) preferred stock into 13.8M common shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 07:00
- Source
- Stock Titan
KARD Price Today: Kardigan, Inc. Stock Price, Quote & Chart
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Jun 2026 13:05
- Source
- mexc.co
Kardigan (KARD) Stock Price At $22 Raises Fresh Valuation Questions
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 20 Jun 2026 07:00
- Source
- Market source
Kardigan rises on market debut after upsized IPO (KARD:NASDAQ)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 07:00
- Source
- Seeking Alpha
Kardigan (KARD) Stock Price, News & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 02:14
- Source
- Stock Titan
Kardigan, Inc. (KARD) stock price, news, quote and history
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 00:21
- Source
- Market source
Puma Biotechnology Stock Rises 19% in 3 Months: Here's Why
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jun 2026 07:00
- Source
- Market source
There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- simplywall.st
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Mar 2026 07:00
- Source
- TradingView
Why Did Puma Biotechnology's Stock Plummet Despite Beating Q4 Estimates
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Feb 2026 09:53
- Source
- Kavout | AI
Cava Stock Surges 24% After Upbeat Earnings and Strong 2026 Outlook
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 26 Feb 2026 08:00
- Source
- TIKR.com
Vir Biotechnology Stock Skyrockets 65% on Positive Prostate Cancer Treatment Trial Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 25 Feb 2026 08:00
- Source
- TIKR.com
Why Did Vir Biotechnology Stock Surge 60% After-Hours Today?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 24 Feb 2026 08:00
- Source
- Stocktwits
This Small-Cap Biotech Stock Is Soaring 29% on Excitement Over Its Prostate Cancer Drug
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Feb 2026 08:00
- Source
- Barron's